Found: 7
Select item for more details and to access through your institution.
Efficacy of visceral fat estimation by dual bioelectrical impedance analysis in detecting cardiovascular risk factors in patients with type 2 diabetes.
- Published in:
- Cardiovascular Diabetology, 2019, v. 18, n. 1, p. N.PAG, doi. 10.1186/s12933-019-0941-y
- By:
- Publication type:
- Article
Effect of tofogliflozin on cardiac and vascular endothelial function in patients with type 2 diabetes and heart diseases: A pilot study.
- Published in:
- Journal of Diabetes Investigation, 2020, v. 11, n. 2, p. 400, doi. 10.1111/jdi.13122
- By:
- Publication type:
- Article
Hypocholesterolemia is a risk factor for reduced systemic vascular resistance reactivity during hemodialysis.
- Published in:
- Hypertension Research, 2021, v. 44, n. 8, p. 988, doi. 10.1038/s41440-021-00640-2
- By:
- Publication type:
- Article
Diabetic microvascular complications predicts non‐heart failure with reduced ejection fraction in type 2 diabetes.
- Published in:
- ESC Heart Failure, 2023, v. 10, n. 2, p. 1158, doi. 10.1002/ehf2.14280
- By:
- Publication type:
- Article
Effect of Luseogliflozin on Myocardial Flow Reserve in Patients with Type 2 Diabetes Mellitus (LUCENT-J Study).
- Published in:
- Diabetes Therapy, 2024, v. 15, n. 5, p. 1245, doi. 10.1007/s13300-024-01571-0
- By:
- Publication type:
- Article
A Prospective Longitudinal Study on the Relationship Between Glucose Fluctuation and Cognitive Function in Type 2 Diabetes: PROPOSAL Study Protocol.
- Published in:
- Diabetes Therapy, 2020, v. 11, n. 11, p. 2729, doi. 10.1007/s13300-020-00916-9
- By:
- Publication type:
- Article
High Stroke Volume Variation Is an Independent Predictor for Decreased Blood Pressure During Hemodialysis.
- Published in:
- Therapeutic Apheresis & Dialysis, 2017, v. 21, n. 2, p. 166, doi. 10.1111/1744-9987.12511
- By:
- Publication type:
- Article